A Phase 3b, Randomized, Single-Blind, Controlled, Comparative Efficacy and Safety Study of Topical Fibrocaps (Raplixa) and Tachosil in Surgical Hemostasis during Hepatic Resection
Phase of Trial: Phase III
Latest Information Update: 18 Aug 2017
Price : $35 *
At a glance
- Drugs Fibrinogen/thrombin (Primary)
- Indications Surgical blood loss
- Focus Registrational; Therapeutic Use
- Acronyms Finish 3b
- Sponsors ProFibrix; The Medicines Company
- 30 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 31 Jul 2015 Status changed from active, no longer recruiting to recruiting as per ClinicalTrials.gov record.
- 28 Jul 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.